These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 21787275)

  • 41. Poly(ethylene glycol)-modified nanocarriers for tumor-targeted and intracellular delivery.
    van Vlerken LE; Vyas TK; Amiji MM
    Pharm Res; 2007 Aug; 24(8):1405-14. PubMed ID: 17393074
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inorganic Nanoparticles for Cancer Therapy: A Transition from Lab to Clinic.
    Bayda S; Hadla M; Palazzolo S; Riello P; Corona G; Toffoli G; Rizzolio F
    Curr Med Chem; 2018; 25(34):4269-4303. PubMed ID: 29284391
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Application of nanotechnology in the treatment and diagnosis of gastrointestinal cancers: review of recent patents.
    Prados J; Melguizo C; Perazzoli G; Cabeza L; Carrasco E; Oliver J; Jiménez-Luna C; Leiva MC; Ortiz R; Álvarez PJ; Aranega A
    Recent Pat Anticancer Drug Discov; 2014 Jan; 9(1):21-34. PubMed ID: 23676104
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Prominent Role of Protein-Based Delivery Systems on the Development of Cancer Treatment.
    Kouchakzadeh H; Abbas Shojaosadati S
    Curr Pharm Des; 2016; 22(22):3455-65. PubMed ID: 26845324
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Strategic targeting of non-small-cell lung cancer utilizing genetic material-based delivery platforms of nanotechnology.
    Chaudhary S; Singh A; Kumar P; Kaushik M
    J Biochem Mol Toxicol; 2021 Jul; 35(7):e22784. PubMed ID: 33826765
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gold nanoparticles in theranostic oncology: current state-of-the-art.
    Akhter S; Ahmad MZ; Ahmad FJ; Storm G; Kok RJ
    Expert Opin Drug Deliv; 2012 Oct; 9(10):1225-43. PubMed ID: 22897613
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New Perspectives in Glioblastoma: Nanoparticles-based Approaches.
    Luciano R; Battafarano G; Saracino R; Rossi M; Perrotta A; Manco M; Muraca M; Del Fattore A
    Curr Cancer Drug Targets; 2017; 17(3):203-220. PubMed ID: 27528362
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Towards the use of nanoparticles in cancer therapy and imaging.
    Pauwels EK; Erba P
    Drug News Perspect; 2007 May; 20(4):213-20. PubMed ID: 17637933
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nanotechnology in the war against cancer: new arms against an old enemy - a clinical view.
    Friberg S; Nyström AM
    Future Oncol; 2015; 11(13):1961-75. PubMed ID: 26161930
    [TBL] [Abstract][Full Text] [Related]  

  • 50. PCL/PEG copolymeric nanoparticles: potential nanoplatforms for anticancer agent delivery.
    Gou M; Wei X; Men K; Wang B; Luo F; Zhao X; Wei Y; Qian Z
    Curr Drug Targets; 2011 Jul; 12(8):1131-50. PubMed ID: 21443476
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nanotechnology applications in thoracic surgery.
    Hofferberth SC; Grinstaff MW; Colson YL
    Eur J Cardiothorac Surg; 2016 Jul; 50(1):6-16. PubMed ID: 26843431
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Improved Targeting of Cancers with Nanotherapeutics.
    Foster C; Watson A; Kaplinsky J; Kamaly N
    Methods Mol Biol; 2017; 1530():13-37. PubMed ID: 28150194
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Current advance of nanotechnology in diagnosis and treatment for malignant tumors.
    Wang B; Hu S; Teng Y; Chen J; Wang H; Xu Y; Wang K; Xu J; Cheng Y; Gao X
    Signal Transduct Target Ther; 2024 Aug; 9(1):200. PubMed ID: 39128942
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Polymer nanoparticulate drug delivery and combination cancer therapy.
    Cao P; Bae Y
    Future Oncol; 2012 Nov; 8(11):1471-80. PubMed ID: 23148619
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nanoparticle therapeutics for prostate cancer treatment.
    Sanna V; Sechi M
    Nanomedicine; 2012 Sep; 8 Suppl 1():S31-6. PubMed ID: 22640911
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Optical imaging-guided cancer therapy with fluorescent nanoparticles.
    Jiang S; Gnanasammandhan MK; Zhang Y
    J R Soc Interface; 2010 Jan; 7(42):3-18. PubMed ID: 19759055
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inorganic nanoparticles for cancer imaging and therapy.
    Huang HC; Barua S; Sharma G; Dey SK; Rege K
    J Control Release; 2011 Nov; 155(3):344-57. PubMed ID: 21723891
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Supramolecular nanoscale assemblies for cancer diagnosis and therapy.
    Coelho SC; Pereira MC; Juzeniene A; Juzenas P; Coelho MAN
    J Control Release; 2015 Sep; 213():152-167. PubMed ID: 26160308
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recent advances in "smart" delivery systems for extended drug release in cancer therapy.
    Kalaydina RV; Bajwa K; Qorri B; Decarlo A; Szewczuk MR
    Int J Nanomedicine; 2018; 13():4727-4745. PubMed ID: 30154657
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy.
    Zhu L; Zhou Z; Mao H; Yang L
    Nanomedicine (Lond); 2017 Jan; 12(1):73-87. PubMed ID: 27876448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.